Evaluating Clinical Challenges Associated with Allogeneic Therapies
Time: 2:00 pm
day: Day 1 Treg Cell Therapy Track
Details:
- Assessing the risks of allogeneic therapies to ensure safe treatment development
- Addressing the persistence of allogeneic therapies without the need for deep lymphodepletion
- Discussing innovations to overcome manufacturing challenges for allogeneic therapies
